LASA SUPERGENERICS
Back to Cashflow Statement
|
LASA SUPERGENERICS Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-0.19 Cr | ₹-10 Cr | ₹6.26 Cr | ₹1.27 Cr | ₹2.15 Cr |
What is the latest Net Cash Inflow / Outflow ratio of LASA SUPERGENERICS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2024 | ₹-0.19 Cr |
| Mar2023 | ₹-10 Cr |
| Mar2022 | ₹6.26 Cr |
| Mar2021 | ₹1.27 Cr |
| Mar2020 | ₹2.15 Cr |
How is Net Cash Inflow / Outflow of LASA SUPERGENERICS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2024 | ₹-0.19 Cr | Negative | |
| Mar2023 | ₹-10 Cr | Negative | |
| Mar2022 | ₹6.26 Cr | 392.83 | |
| Mar2021 | ₹1.27 Cr | -40.88 | |
| Mar2020 | ₹2.15 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of LASA SUPERGENERICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LASA SUPERGENERICS | ₹46.8 Cr | 0.8% | 1.9% | -66.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
LASA SUPERGENERICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LASA SUPERGENERICS | 0.8% |
1.9% |
-66.8% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses